Multicenter prospective study of interferon-α versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: A preliminary analysis

Cancer Chemotherapy and Pharmacology

Volumn 48, Issue SUPPL. 1, 2001, Pages

  Ohnishi, Kazunori ^a   Ino, Teruo ^b   Kishimoto, Yuji ^c   Usui, Noriko ^d   Shimazaki, Chihiro ^e   Ohtake, Shigeki ^f   Taguchi, Hirokuni ^g   Kusumoto, Shuya ^h   Kuriyama, Kazutaka ⁱ   Hotta, Tomomitsu ^j   Ohno, Ryuzo ^k  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

^g KOCHI MEDICAL SCHOOL   (Japan)

^h SAITAMA MEDICAL UNIVERSITY   (Japan)

ⁱ NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOKAI UNIVERSITY   (Japan)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

Bone marrow transplantation; Chronic myelogenous leukemia; Interferon alpha; Prospective multicenter study

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; HYDROXYUREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MYELOID LEUKEMIA; PROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0010387285     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800100307     Document Type: Article

References (14)

1. Anderson J, Cain K, Gelber R (1983) Analysis of survival by tumor response. J Clin Oncol 1:710
2. Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM (1998) Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. Blood 91:1810
3. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962
4. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Loffler H, Hochhaus A, Heinze B (1994) Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. Blood 84:4064
5. Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330:820
6. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation (1999) Monitoring treatment and survival in chronic myeloid leukemia. J Clin Oncol 17:1858
7. Japan Society for Hematopoietic Cell Transplantation Office (1999) The Japan Society for Hematopoietic Cell Transplantation: Annual report of nationwide survey 1999 (in Japanese). JSHCT Monograph 2, p 68
8. Kitajima K, Ishibashi M, Nagao T, Takahashi I, Kinoshita H, Shimada A, Moriwaki Y, Uemura M (1972) Clinical studies on the early diagnosis and treatment of blastic crisis of chronic myelogenous leukemia (in Japanese). Jpn J Clin Hematol 13:560
9. Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R (2000) Multicenter prospective study of interferon alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Int J Hematol 72:229
10. Ohnishi K, Tomonaga M, Kamada N, Onozawa K, Kuramoto A, Dohy H, Mizoguchi H, Miyawaki S, Tsubaki K, Miura Y, Omine M, Kobayashi T, Naoe T, Ohshima T, Hirashima K, Ohtake S, Takahashi I, Morishima Y, Naito K, Asou N, Tanimoto M, Sakuma A, Ohno R (1995) A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase. Blood 86:906
11. Ohnishi K, Tomonaga M, Kamada N, Onozawa K, Kuramoto A, Dohy H, Mizoguchi H, Miyawaki S, Tsubaki K, Miura Y, Omine M, Kobayashi T, Naoe T, Ohshima T, Hirashima K, Ohtake S, Takahashi I, Morishima Y, Naito K, Asou N, Tanimoto M, Sakuma A, Ohno R (1998) A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group. Leuk Res 22:779
12. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, Yoshida T, Kimura A, Akaza T, Kamikawaji N, Kodera Y, Takaku F (1998) Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 339:1177
13. Silver RT, Woolf SH, Hehlmann R, Appelbaum FR, Anderson J, Bennett C, Goldman JM, Guilhot F, Kantarjian HM, Lichtin AE, Talpaz M, Tura S (1999) An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology. Blood 94:1517
14. Talpaz M, Kantarjian H, McCredie K, Keating M, Trujillo R, Gutterman J (1987) Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood 69:1280